These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 907314)

  • 1. Effect of long-acting oestriol on the vaginal cytology of postmenopausal women.
    Purola E; Vartiainen E
    Ann Chir Gynaecol; 1977; 66(4):216-8. PubMed ID: 907314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of polyestriol phosphate on the vaginal cytology and uterine endometrium of postmenopausal women.
    Sjöstedt S; Strandh J
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:30. PubMed ID: 5287101
    [No Abstract]   [Full Text] [Related]  

  • 3. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience].
    Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E
    Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral estriol on urogenital symptoms, vaginal cytology, and plasma hormone level in postmenopausal women.
    Manonai J; Theppisai U
    J Med Assoc Thai; 2001 Apr; 84(4):539-44. PubMed ID: 11460966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms.
    van der Linden MC; Gerretsen G; Brandhorst MS; Ooms EC; Kremer CM; Doesburg WH
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):29-33. PubMed ID: 8282140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
    Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local oestriol treatment improves the structure of elastic fibers in the skin of postmenopausal women.
    Punnonen R; Vaajalahti P; Teisala K
    Ann Chir Gynaecol Suppl; 1987; 202():39-41. PubMed ID: 3477986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
    Bateson DJ; Weisberg E
    Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause.
    Repse-Fokter A; Takac I; Fokter SK
    Gynecol Endocrinol; 2008 Jul; 24(7):399-404. PubMed ID: 18645712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytologic response of the irradiated vagina to estriol succinate].
    Cabrera J; Canahuate E; del Campo SL; Poloni O; Ramírez SI
    Rev Chil Obstet Ginecol; 1993; 58(4):317-22. PubMed ID: 7991851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal women.
    Mattsson LA; Cullberg G
    Acta Obstet Gynecol Scand; 1983; 62(5):397-401. PubMed ID: 6421083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of oestriol in the management of the post-menopause.
    Tzingounis VA; Aksu MF; Greenblatt RB
    Acta Endocrinol Suppl (Copenh); 1980; 233():45-50. PubMed ID: 6773286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the estrogenic potential of two synthetic estrogens (mestranol and ethinylestradiol).
    Teter J; Stupnicki R
    Acta Cytol; 1971; 15(2):167-70. PubMed ID: 5282948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen concentrations in plasma, endometrium, myometrium and vagina of postmenopausal women, and effects of vaginal oestriol (E3) and oestradiol (E2) applications.
    van Haaften M; Donker GH; Haspels AA; Thijssen JH
    J Steroid Biochem; 1989 Oct; 33(4A):647-53. PubMed ID: 2811377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of menopausal complants with polyoestriol-phosphate. Experiences with Gynäsan injections].
    Bachmann FF
    Munch Med Wochenschr; 1971 Jan; 113(5):166-9. PubMed ID: 5107471
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
    Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
    Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.